-
Featured Press Release
Aspira Women’s Health Reports First Quarter 2021 Financial Results
Learn More -
Press Release
Aspira Women’s Health to Reveal 3rd Generation Ovarian Cancer Risk Assessment Technology at ASCO 2021
Learn More -
Press Release
Aspira Women’s Health Initiates Prospective Clinical Study for Benign Risk Monitoring and High Risk Early Ovarian Cancer Detection with Northwell Health®
Learn More
Press Release
Choose a Category:
-
Aspira Women’s Health, Inc. Announces an Agreement for the Development and Commercialization of an Early-Detection Test for Identification of Ovarian Cancer
Press Release
For a PDF of this press release, please click here. AUSTIN, Texas — March 25th, 2021 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced it has entered into an agreement with Dana-Farber Cancer Institute (DFCI), Brigham and Women’s Hospital, and Medical University Lodz to evaluate their novel microRNA (miRNA)…
-
Aspira Women’s Health Inc. to Report Fourth Quarter and Full Year 2020 Financial Results
Press Release
For a pdf of this release please click here AUSTIN, Texas — March 18, 2021 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it will report financial results for the fourth quarter and full year ended December 31st, 2020, on Thursday, March 25th, 2021, after the market close, followed…
-
Aspira Women’s Health Inc. Announcement New York State Medicaid Now Considers OVA1 Medically Necessary as of April 1, 2021
Press Release
Second Largest Medicaid population in the U.S. For a pdf of this release please click here AUSTIN, Texas — March 15, 2021 — Aspira Women’s Health Inc. (Nasdaq: AWH), today announced its wholly owned subsidiary, Aspira Labs, is now credentialed with New York State’s Medicaid program for an estimated additional 6.5 million Medicaid lives. NY…
-
Aspira Women’s Health Inc. Appoints Nicole Sandford to its Board of Directors
Press Release
For a pdf of this press release please click here AUSTIN, Texas — February 22, 2021 — Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced the appointment of Ms. Nicole Sandford to its Board of Directors. “I am very pleased to warmly welcome Nicole to our Board of Directors. She…
-
Aspira Women’s Health Recognizes the Importance of Bridging the Gap in Ovarian Cancer Risk Assessment Disparities During Black History Month
Press Release
For a full pdf of this press release please click here AUSTIN, Texas — February 17, 2021- February is recognized as Black History Month, a time to honor the contributions of Black Americans to culture and society while elevating the voices of those fighting for equity and justice. This month, Aspira Women’s Health Inc. (Nasdaq:…